You may not be eligible for a GLP-1 prescription if you meet any of the following criteria: Currently pregnant, nursing, or planning to become pregnant in the next year Family or personal history of medullary thyroid cancer Personal history of multiple endocrine neoplasia type 2 (MEN2) Active eating disorder or history of eating disorder (bulimia, anorexia, etc.) Currently being treated for cancer Active drug or alcohol misuse Suicidal thoughts or past attempts Mental health disorders (bipolar disorder, anxiety disorder, schizophrenia, etc.) Current or history of pancreatitis Bariatric surgery (within the last 18 months) Heart attack (within the last 12 months) Heart failure Organ transplant or immunosuppressive therapy Severe gastrointestinal diseases such as gastroparesis and inflammatory bowel disease Gallbladder disease Kidney disease Liver disease Diabetic retinopathy Insulin use Atrial fibrillation (A-fib) or tachycardia Weight loss results vary depending on your starting weight, medical conditions, lifestyle changes, and type of weight loss medication

Despite this shift, the Medicare and Medicaid restrictions still remain law of the land, though there are signs of legislative change
Lin, Ai-Ling*
1 Furthermore, the procedure was well tolerated and had no unanticipated or serious adverse effects, remaining consistent with safety concerns
Some patients benefit from temporary dose holds or switching to PlexusDx's compounded tirzepatide injection or GLP-Squared formulations, which may trigger a different side effect profile based on your individual peptide pathway genetics